Immunology and Microbiology
Inflammatory Arthritis
100%
Systemic Lupus Erythematosus
92%
Autoantibodies
57%
Vaccination Policy
36%
Macrophage
34%
Periodontitis
31%
Vasculitis
27%
Influenza
25%
Lupus Erythematosus
24%
Adoptive Immunity
22%
Granulomatosis with Polyangiitis
22%
interferon
21%
Anti-Citrullinated Protein Antibody
21%
Immunoglobulin A
19%
Monospecific Antibody
18%
Varicella Zoster Virus
18%
Neutrophil
17%
Atherosclerosis
17%
Glycation
16%
Neutrophil Granulocyte
16%
ANCA Associated Vasculitis
15%
Autoimmune Disease
15%
Arthritis
14%
T Cell
14%
Tumor Necrosis Factor Alpha
13%
Immunoglobulin M
13%
C-Reactive Protein
13%
Hypoxia Inducible Factor 1
12%
Systemic Scleroderma
12%
Mitogen
12%
Rheumatic Disease
12%
Rheumatoid Factor
12%
Humoral Immunity
11%
Herpes Zoster
11%
Immune Response
11%
Nephritis
11%
Monocyte
11%
Infectious Agent
11%
CD177
10%
B Cell
10%
Cytokine
10%
Porphyromonas gingivalis
10%
Transplant Procedure
9%
Mouse
9%
Kidney Transplantation
9%
Giant Cell Arteritis
9%
Aggregatibacter Actinomycetemcomitans
9%
Interleukin 6
8%
Blood Level
8%
Chemokine
7%
Medicine and Dentistry
Systemic Lupus Erythematosus
36%
Rheumatoid Arthritis
31%
Disease
24%
Disease Activity
20%
Cellular Immunity
18%
Vasculitis
15%
Varicella Zoster Virus
14%
Autoantibodies
13%
Disseminated Herpes Zoster
13%
Influenza Vaccination
12%
Endothelial Cell
11%
ANCA Associated Vasculitis
11%
Advanced Glycation End-Product
10%
Granulomatosis with Polyangiitis
10%
Autofluorescence
10%
Atherosclerosis
10%
Periodontitis
9%
Varicella Zoster Vaccine
9%
Lung Transplantation
9%
Immune Response
9%
Macrophage
9%
T Cell
8%
Cytokine
8%
C Reactive Protein
8%
Neutrophil
8%
Tumor Necrosis Factor
8%
Advanced Glycation End Product Receptor
7%
Carotid Atherosclerosis
7%
Oxidative Stress
7%
Lupus Erythematosus
7%
In Vitro
6%
Influenza A Virus (H1N1)
6%
Mitogen Activated Protein Kinase P38
6%
B Cell
6%
Systemic Scleroderma
6%
Kidney Transplantation
6%
Stromelysin
6%
Fluorine-18
6%
Rheumatic Disease
6%
Anti-Citrullinated Protein Antibody
6%
Giant-Cell Arteritis
6%
Biological Marker
6%
Thiol
6%
Influenza A Virus (H3N2)
5%
Immune System
5%
Antibody Response
5%
Cardiovascular Disease
5%
Systemic Vasculitis
5%
Lupus Nephritis
5%
Transplantation
5%
Keyphrases
High Mobility Group Box 1 (HMGB1)
28%
Systemic Lupus Erythematosus
28%
Healthy Controls
22%
Rheumatoid Arthritis
21%
Macrophages
16%
Rheumatoid Arthritis Patients
14%
Disease Activity
12%
Vaccination
11%
Periodontitis
11%
Systemic Lupus Erythematosus Patient
10%
Autoantibodies
9%
Autoimmune Inflammatory Rheumatic Disease
9%
Varicella Zoster Virus
9%
T Cells
9%
Advanced Glycation End Products
7%
Cellular Immunity
7%
Giant Cell Arteritis
7%
Interferon-α (IFN-α)
7%
Skin Autofluorescence
7%
Transplantation
7%
Placenta
6%
Tumor Necrosis Factor-α
6%
Humoral Immunity
6%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
6%
Free Thiols
6%
Nephritis
6%
Live-attenuated Herpes Zoster Vaccine
6%
Influenza Vaccination
6%
Immune Response
6%
CD177
6%
Cell-mediated Immune Response
6%
Early Rheumatoid Arthritis
6%
Individuals at Risk
6%
Myxovirus Resistance Protein A
6%
Rheumatic Diseases
6%
Herpes Zoster
6%
Anti-citrullinated Protein Antibodies
6%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
5%
Cardiovascular Disease
5%
Autoimmune Disease
5%
Oxidative Stress
5%
Antiphospholipid Syndrome
5%
Cardiovascular Risk
5%
Lupus Nephritis
5%
Interleukin-8
5%
